Clinical Trials Logo

Epistaxis clinical trials

View clinical trials related to Epistaxis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06348485 Completed - Clinical trials for Nasopharyngeal Carcinoma Patients Treated With Curative Radiotherapy

Massive Nasal Bleeding in Patients With NPC Received Curative RT

Start date: December 1, 1994
Phase:
Study type: Observational

To investigate the incidence, predictive markers, and survival impact of massive nasal bleeding in nasopharyngeal carcinoma (NPC) patients who received curative radiotherapy (RT) with/without chemotherapy. A total of 1327 patients with previously untreated, biopsy-proven NPC, and no distant metastasis were retrospective reviewed. Investigators analyzed the occurrence rates of massive nasal bleeding between different characteristics and tried to identify important predictive factors. Investigators compared overall survival between patients with and without massive nasal bleeding by Kaplan-Meier method.

NCT ID: NCT06183918 Completed - Tranexamic Acid Clinical Trials

Tranexamic Acid Dosage for Topical Treatment of Anterior Epistaxis

Tranexamicacid
Start date: December 16, 2021
Phase: Phase 4
Study type: Interventional

Patients with epistaxis usually apply to the emergency department for initial treatment. According to recent research, tranexamic acid is effective in the treatment of epistaxis. The research compare the therapeutic superiority of saline with 500 and 1000 mg doses of topical tranexamic acid in the treatment of anterior epistaxis. The design of the phase 4 clinical trial was randomized controlled double-blind. A total of 152 cases in 3 groups were included in the study. Group 1 was treated with 1000 mg of tranexamic acid, group 2 with 500 mg of tranexamic acid, and group 3 with saline. The primary outcome of the study was bleeding control at the 5th and 10th minutes. Secondary outcomes were determined as the need for salvage therapy, recurrent bleeding within 24 hours, the presence of side effects, and the need for otorhinolaryngology consultation.

NCT ID: NCT05937516 Completed - Epistaxis Nosebleed Clinical Trials

Guidewire Use in Nasotracheal Intubation

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

During nasotracheal intubation, nasopharyngeal trauma and associated bleeding may occur. The investigators think that some of this bleeding is due to trauma to the posterior wall of the nasopharynx. The investigators designed this study, thinking that if nasopharyngeal posterior wall trauma can be prevented, some of these bleedings can be prevented.

NCT ID: NCT05738564 Completed - Nasal Bleeding Clinical Trials

Epinephrine Nebulization Prior to Nasotracheal Intubation

Start date: September 1, 2021
Phase: Phase 3
Study type: Interventional

This randomised, prospective study performed in Ain shams university hospitals over 126 Patients ASA I and ASA II, trauma patients who suffered isolated mandibular fractures and necessitated nasal intubation during general anesthesia. The patients were randomly assigned to one of two equal groups: nasal Lidocaine drops followed by Oxymetazoline nasal drops group (OL) or Epinephrine mixed with Lidocaine as nebulization session (EL) group.

NCT ID: NCT05563129 Completed - Emergencies Clinical Trials

Teaching First Aid and Trauma Management to School Students

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

This proposal aims to describe research that will utilize first aid in primary education students and will attempt to identify the frequency with which the training should be repeated and the type of trainer who will carry out the training program.

NCT ID: NCT05525754 Completed - Clinical trials for The Space Where the Tube Will be Passed in the Internal Nasal Valve Region

Computed Tomography-Guided Nasotracheal Intubation Procedure

Start date: January 1, 2019
Phase:
Study type: Observational

Background: Nasotracheal intubation can lead to severe complications like epistaxis with excessive bleeding. The advancement difficulty of the tube faced during nasal intubation is one of the fundamental causes of this condition. The present study aimed to evaluate the effectiveness of Computed tomography-guided nasotracheal intubation in predicting tube advancement difficulty and preventing epistaxis. Material and Methods: 60 maxillofacial surgery patients were included in the study. The space where the tube will be passed in the internal nasal valve region was measured horizontally (distance between inferior concha and septum) and vertically (distance between inferior concha and hard palate) by Computed Tomography. The patients were divided into two groups, 'easy' (n=28) or 'difficult' (n=32), according to the effort required to advance the tube through the nasal passage. ROC analysis was performed, and cut-off values were determined to reveal the distance values at which difficulty may be experienced while advancing the tube. The cut-off values were 1.09 cm and 0.39 cm for the vertically and horizontally distances, respectively.

NCT ID: NCT05334017 Completed - Epistaxis Clinical Trials

Xylometazoline and Cocaine for Nasal Vasoconstriction

Start date: September 8, 2022
Phase: Phase 4
Study type: Interventional

The objective of this study is to compare xylometazoline and cocaine's effect on minimizing epistaxis when administered as a local vasoconstrictor prior to nasal intubation. The investigators hypothesize that there will be a lower bleeding score in the group receiving xylometazoline as compared with the group receiving cocaine.

NCT ID: NCT04426409 Completed - Intubation Clinical Trials

Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children

Start date: July 8, 2020
Phase: N/A
Study type: Interventional

Nasotracheal intubation is one of the anesthetic procedures required for oral surgery. It allows the surgeon easier access to the surgical site than the orthotracheal intubation. Therefore, nosotracheal intubation is commonly used for general anesthesia for oral and maxillofacial surgery and dental treatment. However, nasotracheal intubation can damage the nasal mucosa in the course of the tube passing through the nostrils, causing epistaxis which is reported as the most common side effect. In order to reduce these side effects, heating of the tube and use of a tube lubricant immediately before intubation have been recommended in children. However, research on whether the dry state of the mucosa itself contributes to the development of epistaxis is limited. A study in adults reported that pretreatment of the ointment on the mucosa reduced the damage to the mucosa. However, its effect on the incidence of epistaxis in children has not been studied. The purpose of this study is to investigate the effects of pretreatment of nasal ointment on epistaxis of nasotracheal intubation in children.

NCT ID: NCT04279288 Completed - Epistaxis Clinical Trials

The Roles of Hilotherapy in the Management of Epistaxis and Nasal Fractures

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The Investigators aimed to assess primarily whether or not Hilotherapy masks are a tolerable treatment for the conservative management of epistaxis and nasal fractures.

NCT ID: NCT04217941 Completed - Epistaxis Clinical Trials

Effect of Practical Demonstration to Use Nasal Spray and Apply Intranasal Ointment on Epistaxis

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

To compare the result of verbally educating the parents about method of intranasal antiseptic cream application versus practically educating and demonstrating how to apply cream intra nasally.